Navigation Links
Ancor and Merit acquire Uplift Technologies for Carex Health Brands

FORT WORTH, Texas, July 10, 2012 /PRNewswire/ --  Ancor Capital Partners and Merit Capital Partners announced the acquisition of Canada-based Uplift Technologies, a leader in the development, manufacturing and sales of seat-assist and light-therapy medical products. With the acquisition, Uplift Technologies will operate through Carex Health Brands Canada, a division of Boston-based Carex Health Brands.  Founded in 1993 in Dartmouth, Nova Scotia, Canada, Uplift Technologies offers clinically proven and patented seat-assist and light-therapy products with its Uplift and Daylight brands.

"This marks our second acquisition in the past year for Carex," said J. Randall Keene, Partner with Ancor and Director of Carex. "Ancor teamed up with Merit Capital approximately two years ago to acquire Carex Health Brands, and our vision was to build the company through both internal growth and acquisitions."

According to Keene, Ancor previously acquired Detach N' Go and its product line of Detachable Pill Cases are now marketed through Carex.

"The acquisition of Uplift is a meaningful step in establishing Carex as the leader in home medical products distributed through retail distribution channels," said Terrance M. Shipp, Managing Director at Merit Capital.

Carex will add the Uplift seat-assist and light-therapy brands to its product lines which include Carex, Apex, Bed Buddy, Thera-Med and Detach N' Go.

"We were impressed with the innovative nature of the Uplift Technologies products," said Matt McElduff, President of Carex.  "The Uplift seat-assist and light-therapy products are an obvious extension of our category-leading Carex brand. We expect to have an immediate impact on sales by leveraging our extensive sales and logistics network. And we will add their existing products to our current broad base of distribution, while continuing to innovate and expand the Uplift categories under the Carex brand."

According to McElduff, the brands marketed by Carex have achieved broad customer awareness in the marketplace and are used by home-care patients, the mobility challenged, senior citizens and members of the general public. Carex is the market leader in branded home-medical equipment sold through drug store chains, mass merchants, DME dealers, grocery retailers and online retailers. In addition, Carex offers one of the broadest product lines in hot/cold pain therapy and medication compliance aids. Carex products also are fully stocked with drug wholesalers who service this retail market.

Ancor Capital Partners, based in Fort Worth, Texas, is an operations-oriented private equity firm focused on lower middle-market manufacturing and distribution companies with EBITDA of $5-$15 million.  Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies.  Ancor's proven track record includes 30 acquisitions to date in health care, consumer and other industries.Contact:

Brook M. Smith, Managing DirectorAncor

SOURCE Ancor Capital Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. Ameritox Announces Educational Resources to Help Physicians Navigate Complex Compliance Issues
3. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
4. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
5. Watson to Acquire Actavis Group for EUR4.25 Billion
6. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
7. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
8. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
9. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
10. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
11. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
Post Your Comments:
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
Breaking Medicine News(10 mins):